William (Rick) Peterson Email & Phone Number

Virginia, United States

Fairfax, Virginia

As Chairman of the Investment Board at Peterson Companies, Rick leads the strategic oversight of all non-real estate assets within the Peterson family's diversified portfolio. This includes financial securities, Private Equity positions, and various business ventures beyond our real estate interests. Under Rick’s guidance, these assets are harmoniously managed to seek synergies in conjunction with the family's extensive real estate holdings. As a Principal at Peterson Companies, Rick brings over 25 years of diverse leadership experience within the family's multi-faceted real estate business. His journey includes serving as CFO (1993-2001) and COO of Asset Management (2001-2008), overseeing financial management, strategic planning, and operational efficiency. Key Achievements: • Propella Therapeutics: Managed highly successful exit of potential blockbuster prostate cancer drug to Astellas Pharma, Inc for $175M.• Managing largest shareholder position at Koios Medical. Koios specializes in integrating AI-enhanced ultrasound software with top devices (e.g., General Electric, Fiji, Phillips), advancing radiologic diagnostics (focus on breast and thyroid cancer).• Member, Peterson Family Governing Board, Enterprise Committee, Peterson Foundation Board & Family Council • Orchestrated asset/property management for a 7 Million sq. ft. (plus) portfolio in Retail and Commercial Office sectors.• Achieved annual revenues exceeding $75 Million.• Restructured and unified all property/asset management under standardized platform on accountability• Directed financial strategies for a multi-product diversified real estate company with annual revenues surpassing $150 Million• Lead multi-year upgrade to accounting, finance and tax departments while achieving a more collaborative “team” approach with Operations• Led external capital management (debt and equity), internal controls, and strategic capital & asset allocation.

Founded to provide a nurturing environment for groundbreaking patented technologies to thrive. As a forward-thinking incubator, our mission is to propel innovation into the next frontier of technological advancement.

Creating SASS software solutions to facilitate the creation and execution of humanitarian response to natural disasters in the U.S. A “turnkey” value chain of components will provide, project management, supplier procurement, logistical placement with full transparency and donor feedback loop

Propella Therapeutics was established in 2020 through a strategic reorganization of Vizuri Consumer Healthcare. The company has successfully developed a platform dedicated to creating best- of, first-in-class oncology drugs. In 2023, Astellas Pharma recognized the potential of Propella and acquired the company for $175 million. This acquisition was primarily influenced by the remarkable success of Propella’s lead drug candidate, specifically designed as a prostate cancer treatmentPropella Therapeutics, Inc.: Propella has developed a mulit-product pipeline of drugs seeking regulatory approval through the 505(b)(2) pathway. It's flagship CGS-200 capsaicin based product is nearing the start of a Phase 2b/3 clinical trial. Other drugs include early stage p[re-clinical development of products in the areas of oncology and viral suppression.

“Serving those who serve others", with an entire value chain of SaaS, cloud-based solutions to optimize supply-side & Gifts In Kind operations”.This was a previous humanitarian endeavor that has been discontinued.As founder and leader of HXI, I was dedicated to providing desperately needed and unique technology solutions for the humanitarian industry. Activities included product ideation & conceptualization, collaboration management, optimal team member recruitment, technology partnering, product specification definition, development of a professional Business Plan and initial accounting/finance & administrative management. HXI was building a SaaS (software as a service) cloud-based technology platform which enables efficient, high integrity development and disaster relief efforts globally. We were devoted to to "serving those who serve others" [in humanitarian need] with high value and accessible technology solutions. Utilizing the cloud and deep technical and business expertise, HXI was to deliver low cost and engaging digital capabilities with unprecedented accountability and transparency for the humanitarian aid industry while amplifying the individual missions and brands of our ecosystem of NGO and governmental agency clientele. HXI was "serving those who serve others", with a seamlessly linked value chain of SaaS, cloud-based modules (solutions) to optimize supply-side & Gifts In Kind operations within the humanitarian aid industry. HXI was joining the wave of entrepreneurial efforts to deliver a superior "bang for the buck" on philanthropic investment into the future. We sought transform the way in which technology is perceived within the humanitarian aid industry by allowing technology expenditures to become a "program costs" as opposed to "overhead".

Mclean, Va

Cardinal Financial Corporation was at one time, one of the largest financial institutions headquartered in Northern Virginia and the Commonwealth of Virginia. Before being merged into United Bank, Cardinal had total assets of over $4 Billion and annual earnings of over $50 Million.

Chantilly, Va

DS3 Datavaulting Company was a successful start-up venture in the data storage and disaster response industry. The company had a profitable exit in 2008.

Belize City, Belize

Bluewater Aquaculture was a shrimp Farming operation in various locations in the country of Belize with (at its peak) over $25 Million in annual sales of processed shrimp.

Mba, Real Estate Finance

Ba